RECQL5 is an important determinant for camptothecin tolerance in human colorectal cancer cells

Bioscience Reports

Volumn 31, Issue 5, 2011, Pages 363-369

  Wang, Xiaoqi ^a,b   Lu, Xincheng ^a   Zhou, Guangjin ^a   Lou, Hua ^a   Luo, Guangbin ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Camptothecin (CPT); Colorectal cancer; Drug tolerance; RECQL5; Topoisomerase I (Topo I) inhibitor

Indexed keywords

BIOLOGICAL MARKER; CAMPTOTHECIN; RECQ HELICASE; RECQ HELICASE L5 PROTEIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; RECQL5 PROTEIN, HUMAN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER RESISTANCE; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; DRUG TOLERABILITY; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN FUNCTION; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; COLORECTAL NEOPLASMS; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; ENZYMOLOGY; FEMALE; GENE INACTIVATION; GENETICS; HCT116 CELL LINE; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR VOLUME;

ADENOVIRIDAE; MUS MUSCULUS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELL SURVIVAL; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE KNOCKOUT TECHNIQUES; HCT116 CELLS; HUMANS; MICE, INBRED BALB C; MICE, NUDE; RECQ HELICASES; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80155145484     PISSN: 01448463     EISSN: None     Source Type: Journal    
DOI: 10.1042/BSR20100108     Document Type: Article

References (19)

1. Pommier, Y. (2006) Topoisomerase I inhibitors: camptothecins and beyond. Nat. Rev. Cancer 6, 789-802
2. Pizzolato, J. F. and Saltz, L. B. (2003) The camptothecins. Lancet 361, 2235-2242 (Pubitemid 36782561)
3. Hsiang, Y. H., Hertzberg, R., Hecht, S. and Liu, L. F. (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem. 260, 14873-14878 (Pubitemid 16211028)
4. Ryan, A. J., Squires, S., Strutt, H. L. and Johnson, R. T. (1991) Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA. Nucleic Acids Res. 19, 3295-3300 (Pubitemid 21912684)
5. Shao, R. G., Cao, C. X., Zhang, H., Kohn, K. W., Wold, M. S. and Pommier, Y. (1999) Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes. EMBO J. 18, 1397-1406 (Pubitemid 29110323)
6. Strumberg, D., Pilon, A. A., Smith, M., Hickey, R., Malkas, L. and Pommier, Y. (2000) Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5′-phosphorylated DNA double-strand breaks by replication runoff. Mol. Cell. Biol. 20, 3977-3987 (Pubitemid 30314496)
7. Furuta, T., Takemura, H., Liao, Z. Y., Aune, G. J., Redon, C., Sedelnikova, O. A., Pilch, D. R., Rogakou, E. P., Celeste, A., Chen, H. T. et al. (2003) Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase 1 cleavage complexes. J. Biol. Chem. 278, 20303-20312 (Pubitemid 36799229)
8. Saltz, L., Shimada, Y. and Khayat, D. (1996) CPT-11 (irinotecan) and 5-fluorouracil: a promising combination for therapy of colorectal cancer. Eur. J. Cancer 32A (Suppl. 3), S24-S31
9. Douillard, J. Y., Cunningham, D., Roth, A. D., Navarro, M., James, R. D., Karasek, P., Jandik, P., Iveson, T., Carmichael, J., Alakl, M. et al. (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355, 1041-1047 (Pubitemid 30162806)
10. Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C. et al. (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N. Engl. J. Med. 351, 337-345 (Pubitemid 38944402)
11. Hu, Y., Lu, X., Barnes, E., Yan, M., Lou, H. and Luo, G. (2005) Recql5 and Blm RecQ DNA helicases have nonredundant roles in suppressing crossovers. Mol. Cell. Biol. 25, 3431-3442 (Pubitemid 40559552)
12. Hu, Y., Raynard, S., Sehorn, M. G., Lu, X., Bussen, W., Zheng, L., Stark, J. M., Barnes, E. L., Chi, P., Janscak, P. et al. (2007) RECQL5/Recql5 helicase regulates homologous recombination and suppresses tumor formation via disruption of Rad51 presynaptic filaments. Genes Dev. 21, 3073-3084 (Pubitemid 350223525)
13. Hu, Y., Lu, X., Zhou, G., Barnes, E. L. and Luo, G. (2009) Recql5 plays an important role in DNA replication and cell survival after camptothecin treatment. Mol. Biol. Cell 20, 114-123
14. Rago, C., Vogelstein, B. and Bunz, F. (2007) Genetic knockouts and knockins in human somatic cells. Nat. Protoc. 2, 2734-2746
15. Zhou, G., Liu, Y., Wu, S. -Y., Tie, F., Lou, H., Chiang, C. -M. and Luo, G. (2009) Purification of a novel RECQL5-SWI/SNF-RNAPII super complex. Int. J. Biochem. Mol. Biol. 1, 101-111
16. Liu, L., Yan, L., Donze, J. R. and Gerson, S. L. (2003) Blockage of abasic site repair enhances antitumor efficacy of 1,3-bis-(2-chloroethyl)-1- nitrosourea in colon tumor xenografts. Mol. Cancer Ther. 2, 1061-1066
17. Abdel-Rahman, W. M., Katsura, K., Rens, W., Gorman, P. A., Sheer, D., Bicknell, D., Bodmer, W. F., Arends, M. J., Wyllie, A. H. and Edwards, P. A. (2001) Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement. Proc. Natl. Acad. Sci. U.S.A. 98, 2538-2543 (Pubitemid 32209517)
18. Zhou, Y., Gwadry, F. G., Reinhold, W. C., Miller, L. D., Smith, L. H., Scherf, U., Liu, E. T., Kohn, K. W., Pommier, Y. and Weinstein, J. N. (2002) Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose-and time-dependent effects. Cancer Res. 62, 1688-1695 (Pubitemid 34408490)
19. Rahden-Staron, I., Szumilo, M., Grosicka, E., Kraakman van der Zwet, M. and Zdzienicka, M. Z. (2003) Defective Brca2 influences topoisomerase I activity in mammalian cells. Acta Biochim. Pol. 50, 139-144 (Pubitemid 37034235)